Celopharma, in collaboration with Health Canada, is issuing this communication to healthcare professionals to clarify the different requirements and steps to follow in order to prescribe, order, stock, and/or dispense MIFEGYMISO, as outlined in the Distribution and Administration Program that is associated with MIFEGYMISO’s approval in Canada.